Cresco Labs to Report Second Quarter 2023 Financial Results on August 16, 2023
Business Wire

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) (“Cresco” or “the Company”), a vertically integrated, multi-state operator and the cannabis industry’s No. 1 producer of branded products, today announced it will report financial results for the second quarter 2023 on Wednesday, August 16th, 2023 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights.


Cresco Labs Second Quarter 2023 Earnings Conference Call


Wednesday, August 16th, 2023


8:30 am EST




1-833-470-1428 (US Toll Free), 1-404-975-4839 (US Local)

Access Code:


Archived access to the webcast will be available for one year on the Cresco Labs investor relations website.

About Cresco Labs

Cresco Labs is one of the largest vertically integrated, multi-state cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. Employing a consumer-packaged goods (“CPG”) approach, Cresco Labs is the largest wholesaler of branded cannabis products in the U.S. Its brands are designed to meet the needs of all consumer segments and comprised of some of the most recognized and trusted national brands including Cresco®, High Supply®, Mindy’s™, Good News®, Remedi™, Wonder Wellness Co.® and FloraCal Farms®. Cresco Labs’ national dispensary brand, Sunnyside®, is a wellness-focused retailer created to build trust, education and convenience for both existing and new cannabis consumers. Recognizing that the cannabis industry is poised to become one of the leading job creators in the country, Cresco Labs operates the industry’s largest Social Equity and Educational Development initiative, SEED™, which was established to ensure that all members of society have the skills, knowledge and opportunity to work and own businesses in the cannabis industry. Learn more about Cresco Labs at

Facebook: Cresco Labs

Instagram: Cresco Labs

Twitter: Cresco Labs

View source version on


Jason Erkes, Cresco Labs
Chief Communications Officer

Megan Kulick, Cresco Labs
Senior Vice President, Investor Relations

For general Cresco Labs inquiries:

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$NRTI Introduces The First Branded CBD-Based Nutritional Supplement

Inergetics Introduces Nulief™, The First Branded Cannabinoid (CBD)-Based Nutritional Supplement Nulief is…

$GRNH Becomes Exclusive Vendor for Leading Cannabis Broker

Greengro Technologies Becomes Exclusive Vendor for Leading Cannabis Broker Canna 1 Advisors…

Nabis Holdings (NAB) (NABIF) Announces Strategic Investment in Bloombox

Nabis Holdings Announces Strategic Investment in Bloombox – a Leading Intelligent Retail…

United Cannabis Corporation (CNAB)Enters Partnership With The NuAxess 2, Inc. Self-Funded Health Insurance Platform

United Cannabis Corporation Enters Partnership With The NuAxess 2, Inc. Self-Funded Health…